John J. Nemunaitis
US Oncology
Dallas
USA
Name/email consistency: high
- Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer. Nemunaitis, J., Sterman, D., Jablons, D., Smith, J.W., Fox, B., Maples, P., Hamilton, S., Borellini, F., Lin, A., Morali, S., Hege, K. J. Natl. Cancer Inst. (2004)
- Phase I trial of topotecan in combination with gemcitabine in refractory solid tumor patients. Nemunaitis, J., Cunningham, C.C., Vukelja, S., Ruxer, R.L., Adams, N., Rich, D., Paulson, A.S., MacEachern, J.B. Cancer Invest. (2004)
- Phase I study of oral CI-994 in combination with gemcitabine in treatment of patients with advanced cancer. Nemunaitis, J.J., Orr, D., Eager, R., Cunningham, C.C., Williams, A., Mennel, R., Grove, W., Olson, S. Cancer. J (2003)
- Enhanced oncolytic potency of replicative adenovirus expressing p53. Nemunaitis, J., Cunningham, C., Senzer, N. Drug Resist. Updat. (2003)
- Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients. Nemunaitis, J., Cunningham, C., Tong, A.W., Post, L., Netto, G., Paulson, A.S., Rich, D., Blackburn, A., Sands, B., Gibson, B., Randlev, B., Freeman, S. Cancer Gene Ther. (2003)
- Selective replicating viral vectors : potential for use in cancer gene therapy. Nemunaitis, J. BioDrugs (2003)
- GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer. Nemunaitis, J. J. Control. Release (2003)
- Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Nemunaitis, J., Cunningham, C., Senzer, N., Kuhn, J., Cramm, J., Litz, C., Cavagnolo, R., Cahill, A., Clairmont, C., Sznol, M. Cancer Gene Ther. (2003)
- Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region. Edelman, J., Edelman, J., Nemunaitis, J. Curr. Opin. Mol. Ther. (2003)
- Head and neck cancer: gene therapy approaches. Part 1: adenoviral vectors. Nemunaitis, J., O'Brien, J. Expert. Opin. Biol. Ther (2002)
- Head and neck cancer: gene therapy approaches. Part II: genes delivered. Nemunaitis, J., O'Brien, J. Expert. Opin. Biol. Ther (2002)
- Selectively replicating viral vectors. Nemunaitis, J., Edelman, J. Cancer Gene Ther. (2002)
- Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. Nemunaitis, J., Khuri, F., Ganly, I., Arseneau, J., Posner, M., Vokes, E., Kuhn, J., McCarty, T., Landers, S., Blackburn, A., Romel, L., Randlev, B., Kaye, S., Kirn, D. J. Clin. Oncol. (2001)
- Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma. Nemunaitis, J., Fong, T., Shabe, P., Martineau, D., Ando, D. Cancer Invest. (2001)
- Virus-mediated killing of cells that lack p53 activity. Nemunaitis, J., Senzer, N., Cunningham, C., Dubensky, T.W. Drug Resist. Updat. (2001)
- Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumors. Nemunaitis, J., Eager, R., Twaddell, T., Corey, A., Sekar, K., Tkaczuk, K., Thompson, J., Hoff, P.M., Pazdur, R. J. Clin. Oncol. (2000)
- Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Nemunaitis, J., Ganly, I., Khuri, F., Arseneau, J., Kuhn, J., McCarty, T., Landers, S., Maples, P., Romel, L., Randlev, B., Reid, T., Kaye, S., Kirn, D. Cancer Res. (2000)
- Biological approaches to treatment of head and neck cancer. Nemunaitis, J., O'Brien, J. BioDrugs (2000)
- Cancer treatment involving oncolytic viruses. Nemunaitis, J.J. Clin. Lung. Cancer (1999)
